Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma

Jing Bian,Wenji Xiong,Zhiguang Yang,Minzhe Li,Demei Song,Yanli Zhang,Chaoying Liu

DOI: https://doi.org/10.1038/s41598-024-51182-9

IF: 4.6

2024-01-05

Scientific Reports

Abstract:S -palmitoylases and S -depalmitoylases are differentially expressed in various cancers and several malignant tumors and show a strong prognostic ability. Notwithstanding, the potential clinical impact of S -palmitoylases and S -depalmitoylases, particularly in the prognosis and progression of lung adenocarcinoma (LUAD), has not been clarified. Expression levels of S -palmitoylases and S -depalmitoylases in LUAD were investigated using TCGA. GEPIA was used to evaluate the mRNA levels of S -palmitoylases and S -depalmitoylases at different pathological stages. Metascape was used to investigate the biological significance of S -palmitoylases and S -depalmitoylases. The Kaplan–Meier plotter was used to analyze the prognostic value of S -palmitoylases and S -depalmitoylases. CBioportal was used to analyze gene alterations in S -palmitoylases and S -depalmitoylases. UALCAN was used to examine DNA promoter methylation levels of S -palmitoylases and S -depalmitoylases. Finally, we investigated the relationship between S -palmitoylases, S -depalmitoylases, and tumor-infiltrating immune cells using TIMER. Correlations with immune checkpoint-related genes were determined using the R packages reshape2 , ggpubr, ggplot2, and corrplot . PCR was also performed to assess the degree of ZDHHC4/12/18/24 and APT2 transcript expression in lung adenocarcinoma and adjacent normal lung tissues. HPA was utilized to investigate protein levels of S -palmitoylases and S -depalmitoylases in LUAD and normal lung tissue. Our study found that ZDHHC2/3/4/5/6/7/9/12/13/16/18/20/21/23/24, APT1/2, PPT1, LYPLAL1, ABHD4/10/11/12/13 and ABHD17C mRNA expression was significantly upregulated in LUAD, whereas ZDHHC1/8/11/11B/14/15/17/19/22, ABHD6/16A and ABHD17A mRNA expression was significantly downregulated. The functions of the differentially expressed S -palmitoylases and S -depalmitoylases were mainly associated with protein-cysteine S -palmitoyltransferase and protein-cysteine S -acyltransferase activities. Patients with high expression of ZDHHC4/12/18/24 , APT2, ABHD4, ABHD11 and ABHD12 had a shorter overall survival. Infiltration of six immune cells (B cells, CD8 + T cells, CD4 + T cells, macrophages, neutrophils, and dendritic cells) was closely associated with the expression of ZDHHC4/12/18/24 and APT2 . ZDHHC4/12/18/24 and APT2 positively correlated with the immune checkpoint-related gene CD276. We assessed the mRNA levels of ZDHHC4/12/18/24 and APT2 using qRT-PCR and found increased expression of ZDHHC4/12/18/24 in LUAD compared with healty control lung tissues. ZDHHC4/12/18/24 , and APT2 are potential prognostic biomarkers of LUAD. Their expression levels could be related to the tumor microenvironment in LUAD.

multidisciplinary sciences